These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21122474)

  • 1. Gene therapy for vision loss -- recent developments.
    Stieger K; Lorenz B
    Discov Med; 2010 Nov; 10(54):425-33. PubMed ID: 21122474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene replacement therapy rescues photoreceptor degeneration in a murine model of Leber congenital amaurosis lacking RPGRIP.
    Pawlyk BS; Smith AJ; Buch PK; Adamian M; Hong DH; Sandberg MA; Ali RR; Li T
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3039-45. PubMed ID: 16123399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leber congenital amaurosis: genes, proteins and disease mechanisms.
    den Hollander AI; Roepman R; Koenekoop RK; Cremers FP
    Prog Retin Eye Res; 2008 Jul; 27(4):391-419. PubMed ID: 18632300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for Leber congenital amaurosis.
    Bennett J
    Novartis Found Symp; 2004; 255():195-202; discussion 202-7. PubMed ID: 14750605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
    Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
    Gene Ther; 2007 Feb; 14(4):292-303. PubMed ID: 17024105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. tgAAG76, an adeno-associated virus delivered gene therapy for the potential treatment of vision loss caused by RPE65 gene abnormalities.
    Stieger K
    Curr Opin Mol Ther; 2010 Aug; 12(4):471-7. PubMed ID: 20677098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of gene therapy on visual function in Leber's congenital amaurosis.
    Bainbridge JW; Smith AJ; Barker SS; Robbie S; Henderson R; Balaggan K; Viswanathan A; Holder GE; Stockman A; Tyler N; Petersen-Jones S; Bhattacharya SS; Thrasher AJ; Fitzke FW; Carter BJ; Rubin GS; Moore AT; Ali RR
    N Engl J Med; 2008 May; 358(21):2231-9. PubMed ID: 18441371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy restores vision-dependent behavior as well as retinal structure and function in a mouse model of RPE65 Leber congenital amaurosis.
    Pang JJ; Chang B; Kumar A; Nusinowitz S; Noorwez SM; Li J; Rani A; Foster TC; Chiodo VA; Doyle T; Li H; Malhotra R; Teusner JT; McDowell JH; Min SH; Li Q; Kaushal S; Hauswirth WW
    Mol Ther; 2006 Mar; 13(3):565-72. PubMed ID: 16223604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful RPE65 gene replacement and improved visual function in humans.
    Koenekoop RK
    Ophthalmic Genet; 2008 Sep; 29(3):89-91. PubMed ID: 18766986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of recombinant adeno-associated virus type 2-RPE65 vector delivered by ocular subretinal injection.
    Jacobson SG; Acland GM; Aguirre GD; Aleman TS; Schwartz SB; Cideciyan AV; Zeiss CJ; Komaromy AM; Kaushal S; Roman AJ; Windsor EA; Sumaroka A; Pearce-Kelling SE; Conlon TJ; Chiodo VA; Boye SL; Flotte TR; Maguire AM; Bennett J; Hauswirth WW
    Mol Ther; 2006 Jun; 13(6):1074-84. PubMed ID: 16644289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal degeneration 12 (rd12): a new, spontaneously arising mouse model for human Leber congenital amaurosis (LCA).
    Pang JJ; Chang B; Hawes NL; Hurd RE; Davisson MT; Li J; Noorwez SM; Malhotra R; McDowell JH; Kaushal S; Hauswirth WW; Nusinowitz S; Thompson DA; Heckenlively JR
    Mol Vis; 2005 Feb; 11():152-62. PubMed ID: 15765048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.
    Jacobson SG; Boye SL; Aleman TS; Conlon TJ; Zeiss CJ; Roman AJ; Cideciyan AV; Schwartz SB; Komaromy AM; Doobrajh M; Cheung AY; Sumaroka A; Pearce-Kelling SE; Aguirre GD; Kaushal S; Maguire AM; Flotte TR; Hauswirth WW
    Hum Gene Ther; 2006 Aug; 17(8):845-58. PubMed ID: 16942444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical gene therapy for the treatment of RPE65-associated Leber congenital amaurosis.
    Stein L; Roy K; Lei L; Kaushal S
    Expert Opin Biol Ther; 2011 Mar; 11(3):429-39. PubMed ID: 21299439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus mediated gene therapy for retinal degenerative diseases.
    Stieger K; Cronin T; Bennett J; Rolling F
    Methods Mol Biol; 2011; 807():179-218. PubMed ID: 22034031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent breakthroughs in gene therapy for inherited retinal degeneration.
    Revere KE; Chung DC
    Discov Med; 2009 Oct; 8(42):125-9. PubMed ID: 19833058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success.
    Jacobson SG; Aleman TS; Cideciyan AV; Sumaroka A; Schwartz SB; Windsor EA; Traboulsi EI; Heon E; Pittler SJ; Milam AH; Maguire AM; Palczewski K; Stone EM; Bennett J
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6177-82. PubMed ID: 15837919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.
    Aguirre GK; Komáromy AM; Cideciyan AV; Brainard DH; Aleman TS; Roman AJ; Avants BB; Gee JC; Korczykowski M; Hauswirth WW; Acland GM; Aguirre GD; Jacobson SG
    PLoS Med; 2007 Jun; 4(6):e230. PubMed ID: 17594175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.
    Rolling F; Le Meur G; Stieger K; Smith AJ; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Péréon Y; Cherel Y; Ali RR; Hamel C; Moullier P; Rolling F
    Bull Mem Acad R Med Belg; 2006; 161(10-12):497-508; discussion 508-9. PubMed ID: 17503728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electroretinographic analyses of Rpe65-mutant rd12 mice: developing an in vivo bioassay for human gene therapy trials of Leber congenital amaurosis.
    Roman AJ; Boye SL; Aleman TS; Pang JJ; McDowell JH; Boye SE; Cideciyan AV; Jacobson SG; Hauswirth WW
    Mol Vis; 2007 Sep; 13():1701-10. PubMed ID: 17960108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of leber congenital amaurosis due to RPE65 mutations by ocular subretinal injection of adeno-associated virus gene vector: short-term results of a phase I trial.
    Hauswirth WW; Aleman TS; Kaushal S; Cideciyan AV; Schwartz SB; Wang L; Conlon TJ; Boye SL; Flotte TR; Byrne BJ; Jacobson SG
    Hum Gene Ther; 2008 Oct; 19(10):979-90. PubMed ID: 18774912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.